“This gives consumers another option for occasional redness relief, using a medication ophthalmologists have worked with for years at higher prescription strengths,” says Bavand Youssefzadeh, DO, an ophthalmologist with Cedars-Sinai in Los Angeles and a cofounder of the Global LASIK and Cataract Institute, both in California, who wasn’t involved with the product’s development.
“What’s new is the lower-concentration, nonprescription formulation for redness caused by minor irritation,” Dr. Youssefzadeh says.
There are a few limitations to consider before you try Brytly, including how often to apply it.
Brytly Whitens Eyes by Narrowing Blood Vessels
Brytly (apraclonidine ophthalmic solution 0.125%) works by stimulating alpha-adrenergic receptors in the eye. “This causes blood vessels on the surface of the eye to narrow and become less visible,” Youssefzadeh says.
Brytly isn’t the first drug in this class available without a prescription. “This is the first OTC apraclonidine product, rather than the first redness drop of this general type,” Youssefzadeh says. Another well-known OTC product, Lumify Redness Reliever Eye Drops, contains the active ingredient brimonidine, which belongs to the same broad drug family and can reduce eye redness for up to 8 hours.
Youssefzadeh says Brytly is simply another choice for consumers to treat eye redness. He cautions against assuming that Brytly is “better” than Lumify because it lasts longer. “I would avoid assuming it has less rebound redness or better tolerability without comparative data,” he says.
Source link